Hematopoietic stem cell mobilizing agents G-CSF, cyclophosphamide or AMD3100 have distinct mechanisms of action on bone marrow HSC niches and bone formation
WINKLER, I. G, PETTIT, A. R, LEVESQUE, J.-P, RAGGATT, L. J, JACOBSEN, R. N, FORRISTAL, C. E, BARBIER, V, NOWLAN, B, CISTERNE, A, BENDALL, L. J, SIMS, N. A
Published in Leukemia (01.07.2012)
Published in Leukemia (01.07.2012)
Get full text
Journal Article
Hypoxia inducible factor (HIF)-2α accelerates disease progression in mouse models of leukemia and lymphoma but is not a poor prognosis factor in human AML
Forristal, C E, Brown, A L, Helwani, F M, Winkler, I G, Nowlan, B, Barbier, V, Powell, R J, Engler, G A, Diakiw, S M, Zannettino, A C W, Martin, S, Pattabiraman, D, D'Andrea, R J, Lewis, I D, Levesque, J P
Published in Leukemia (01.10.2015)
Published in Leukemia (01.10.2015)
Get full text
Journal Article
HIF-1α is required for hematopoietic stem cell mobilization and 4-prolyl hydroxylase inhibitors enhance mobilization by stabilizing HIF-1α
Forristal, C E, Nowlan, B, Jacobsen, R N, Barbier, V, Walkinshaw, G, Walkley, C R, Winkler, I G, Levesque, J P
Published in Leukemia (01.06.2015)
Published in Leukemia (01.06.2015)
Get full text
Journal Article
HIF-1[alpha] is required for hematopoietic stem cell mobilization and 4-prolyl hydroxylase inhibitors enhance mobilization by stabilizing HIF-1[alpha]
Forristal, C.E, Nowlan, B, Jacobsen, R.N, Barbier, V, Walkinshaw, G, Walkley, C.R, Winkler, I.G, Levesque, J.P
Published in Leukemia (01.06.2015)
Published in Leukemia (01.06.2015)
Get full text
Journal Article
Hypoxia inducible factor (HIF)-2[alpha] accelerates disease progression in mouse models of leukemia and lymphoma but is not a poor prognosis factor in human AML
ristal, C E, Brown, A L, Helwani, F M, Winkler, I G, Nowlan, B, Barbier, V, Powell, R J, Engler, G A, Diakiw, S M, Zannettino, A C W, Martin, S, Pattabiraman, D, D'andrea, R J, Lewis, I D, Levesque, J P
Published in Leukemia (01.10.2015)
Published in Leukemia (01.10.2015)
Get full text
Journal Article